RGVJX | UGSFX | RGVJX / UGSFX | |
Total Expense Ratio | 0.40 | 0.69 | 58% |
Annual Report Gross Expense Ratio | 0.44 | 0.73 | 60% |
Fund Existence | 9 years | 24 years | - |
Gain YTD | 4.097 | 4.022 | 102% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 22.2B | 22.2B | 100% |
Annual Yield % from dividends | 4.34 | 4.05 | 107% |
Returns for 1 year | 8.80 | 8.48 | 104% |
Returns for 3 years | 3.09 | 2.28 | 136% |
Returns for 5 years | -6.82 | -8.08 | 84% |
Returns for 10 years | N/A | 4.21 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BRMAX | 14.05 | 0.08 | +0.57% |
iShares Russell Mid-Cap Index Inv A | |||
APHDX | 20.71 | 0.09 | +0.44% |
Artisan Global Discovery Institutional | |||
PMPIX | 78.28 | N/A | N/A |
ProFunds Precious Metals UltraSector Inv | |||
OMGNX | 52.54 | N/A | N/A |
Invesco Main Street R | |||
FBTDX | 102.80 | N/A | N/A |
Franklin Biotechnology Discovery C |